{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T15:44:24Z","timestamp":1792079064172,"version":"4.4.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T00:00:00Z","timestamp":1787788800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100001320","name":"Roswell Park Comprehensive Cancer Center","doi-asserted-by":"publisher","award":["P30CA016056"],"award-info":[{"award-number":["P30CA016056"]}],"id":[{"id":"10.13039\/100001320","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["23K14600"],"award-info":[{"award-number":["23K14600"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.modpat.2026.101072","type":"journal-article","created":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T23:39:26Z","timestamp":1787701166000},"page":"101072","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["A Transcriptional ILCness Score Reveals Lobular-like Biology and Clinical Behavior Beyond CDH1 Mutation Status"],"prefix":"10.1016","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1404-1570","authenticated-orcid":false,"given":"Masanori","family":"Oshi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sasagu","family":"Kurozumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayu","family":"Hizume","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akimitsu","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zunairah","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Itaru","family":"Endo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuaki","family":"Takabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.modpat.2026.101072_bib1","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13058-020-01384-6","article-title":"Invasive lobular carcinoma of the breast: the increasing importance of this special subtype","volume":"23","author":"McCart Reed","year":"2021","journal-title":"Breast Cancer Res"},{"issue":"2","key":"10.1016\/j.modpat.2026.101072_bib2","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s10549-022-06572-w","article-title":"Invasive lobular carcinoma: an understudied emergent subtype of breast cancer","volume":"193","author":"Mouabbi","year":"2022","journal-title":"Breast Cancer Res Treat"},{"issue":"3-4","key":"10.1016\/j.modpat.2026.101072_bib3","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1053\/j.seminoncol.2024.05.001","article-title":"Invasive lobular breast cancer: focus on prevention, genetics, diagnosis, and treatment","volume":"51","author":"Corso","year":"2024","journal-title":"Semin Oncol"},{"issue":"1","key":"10.1016\/j.modpat.2026.101072_bib4","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1245\/s10434-025-18259-9","article-title":"Molecular and biological features of invasive lobular carcinoma: toward new treatment strategies","volume":"33","author":"Ozawa","year":"2026","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"10.1016\/j.modpat.2026.101072_bib5","doi-asserted-by":"crossref","first-page":"446","DOI":"10.14740\/wjon2529","article-title":"Invasive lobular carcinoma has higher immune response than invasive ductal carcinoma in estrogen receptor-positive\/human epidermal growth factor receptor 2-negative breast cancers","volume":"16","author":"Yee","year":"2025","journal-title":"World J Oncol"},{"issue":"1","key":"10.1016\/j.modpat.2026.101072_bib6","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41698-024-00508-x","article-title":"Genomic and epigenomic basis of breast invasive lobular carcinomas lacking CDH1 genetic alterations","volume":"8","author":"Dopeso","year":"2024","journal-title":"NPJ Precis Oncol"},{"key":"10.1016\/j.modpat.2026.101072_bib7","article-title":"CDH1 loss remodels gene expression and lineage identity in human mammary epithelial cells","author":"Musick","year":"2025","journal-title":"bioRxiv"},{"issue":"1","key":"10.1016\/j.modpat.2026.101072_bib8","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s40364-022-00427-8","article-title":"Development of a novel BRCAness score that predicts response to PARP inhibitors","volume":"10","author":"Oshi","year":"2022","journal-title":"Biomark Res"},{"issue":"12","key":"10.1016\/j.modpat.2026.101072_bib9","doi-asserted-by":"crossref","first-page":"3557","DOI":"10.3390\/cancers12123557","article-title":"Degree of early estrogen response predict survival after endocrine therapy in primary and metastatic ER-positive breast cancer","volume":"12","author":"Oshi","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"7403","key":"10.1016\/j.modpat.2026.101072_bib10","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/nature10983","article-title":"The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups","volume":"486","author":"Curtis","year":"2012","journal-title":"Nature"},{"issue":"1a","key":"10.1016\/j.modpat.2026.101072_bib11","first-page":"A68","article-title":"The Cancer Genome Atlas (TCGA): an immeasurable source of knowledge","volume":"19","author":"Tomczak","year":"2015","journal-title":"Contemp Oncol (Pozn)"},{"issue":"18","key":"10.1016\/j.modpat.2026.101072_bib12","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1001\/jama.2011.593","article-title":"A genomic predictor of response and survival following taxane-anthracycline chemotherapy for invasive breast cancer","volume":"305","author":"Hatzis","year":"2011","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.modpat.2026.101072_bib13","doi-asserted-by":"crossref","DOI":"10.1186\/bcr2468","article-title":"Effect of training-sample size and classification difficulty on the accuracy of genomic predictors","volume":"12","author":"Popovici","year":"2010","journal-title":"Breast Cancer Res"},{"issue":"8","key":"10.1016\/j.modpat.2026.101072_bib14","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/nbt.1665","article-title":"The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models","volume":"28","author":"Shi","year":"2010","journal-title":"Nat Biotechnol"},{"issue":"7","key":"10.1016\/j.modpat.2026.101072_bib15","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.ccell.2021.05.009","article-title":"Durvalumab with olaparib and paclitaxel for high-risk HER2-negative stage II\/III breast cancer: results from the adaptively randomized I-SPY2 trial","volume":"39","author":"Pusztai","year":"2021","journal-title":"Cancer Cell"},{"issue":"4","key":"10.1016\/j.modpat.2026.101072_bib16","doi-asserted-by":"crossref","DOI":"10.1186\/bcr2611","article-title":"Changes in expression of oestrogen regulated and proliferation genes with neoadjuvant treatment highlight heterogeneity of clinical resistance to the aromatase inhibitor, letrozole","volume":"12","author":"Miller","year":"2010","journal-title":"Breast Cancer Res"},{"issue":"1","key":"10.1016\/j.modpat.2026.101072_bib17","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/tpj.2010.67","article-title":"Sequential changes in gene expression profiles in breast cancers during treatment with the aromatase inhibitor, letrozole","volume":"12","author":"Miller","year":"2012","journal-title":"Pharmacogenomics J"},{"issue":"2065","key":"10.1016\/j.modpat.2026.101072_bib18","article-title":"Principal component analysis: a review and recent developments","volume":"374","author":"Jolliffe","year":"2016","journal-title":"Philos Trans A Math Phys Eng Sci"},{"key":"10.1016\/j.modpat.2026.101072_bib19","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2105-14-7","article-title":"GSVA: gene set variation analysis for microarray and RNA-seq data","volume":"14","author":"H\u00e4nzelmann","year":"2013","journal-title":"BMC Bioinformatics"},{"issue":"11","key":"10.1016\/j.modpat.2026.101072_bib20","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1038\/s41592-023-02014-7","article-title":"Extending support for mouse data in the Molecular Signatures Database (MSigDB)","volume":"20","author":"Castanza","year":"2023","journal-title":"Nat Methods"},{"issue":"2","key":"10.1016\/j.modpat.2026.101072_bib21","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s10549-022-06633-0","article-title":"Abundance of reactive oxygen species (ROS) is associated with tumor aggressiveness, immune response, and worse survival in breast cancer","volume":"194","author":"Oshi","year":"2022","journal-title":"Breast Cancer Res Treat"},{"issue":"6","key":"10.1016\/j.modpat.2026.101072_bib22","first-page":"3070","article-title":"G2M checkpoint pathway alone is associated with drug response and survival among cell proliferation-related pathways in pancreatic cancer","volume":"11","author":"Oshi","year":"2021","journal-title":"Am J Cancer Res"},{"issue":"1","key":"10.1016\/j.modpat.2026.101072_bib23","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/s41523-022-00466-2","article-title":"Enhanced immune response outperform aggressive cancer biology and is associated with better survival in triple-negative breast cancer","volume":"8","author":"Oshi","year":"2022","journal-title":"NPJ Breast Cancer"},{"issue":"4","key":"10.1016\/j.modpat.2026.101072_bib24","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1097\/SLA.0000000000006428","article-title":"Infiltration of common myeloid progenitor (CMP) cells is associated with less aggressive tumor biology, lower risk of brain metastasis, better response to immunotherapy, and higher patient survival in breast cancer","volume":"280","author":"Oshi","year":"2024","journal-title":"Ann Surg"},{"issue":"18","key":"10.1016\/j.modpat.2026.101072_bib25","doi-asserted-by":"crossref","first-page":"6968","DOI":"10.3390\/ijms21186968","article-title":"CD8 T cell score as a prognostic biomarker for triple negative breast cancer","volume":"21","author":"Oshi","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10.1016\/j.modpat.2026.101072_bib26","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1038\/s41417-024-00756-w","article-title":"Enhanced epithelial-mesenchymal transition signatures are linked with adverse tumor microenvironment, angiogenesis and worse survival in gastric cancer","volume":"31","author":"Oshi","year":"2024","journal-title":"Cancer Gene Ther"},{"key":"10.1016\/j.modpat.2026.101072_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2023.113250","article-title":"Absence of lobular carcinoma in situ is a poor prognostic marker in invasive lobular carcinoma","volume":"191","author":"Mouabbi","year":"2023","journal-title":"Eur J Cancer"},{"issue":"2","key":"10.1016\/j.modpat.2026.101072_bib28","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s10549-022-06567-7","article-title":"Multi-omics analyses provide novel biological insights to distinguish lobular ductal types of invasive breast cancers","volume":"193","author":"Sivadas","year":"2022","journal-title":"Breast Cancer Res Treat"},{"issue":"15","key":"10.1016\/j.modpat.2026.101072_bib29","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1200\/JCO.2020.38.15_suppl.1586","article-title":"Comparison of genomic instability test scores used for predicting PARP activity in ovarian cancer","volume":"38","author":"Timms","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.modpat.2026.101072_bib30","doi-asserted-by":"crossref","first-page":"416","DOI":"10.3389\/fimmu.2015.00416","article-title":"Maintenance of immune homeostasis through ILC\/T cell interactions","volume":"6","author":"von Burg","year":"2015","journal-title":"Front Immunol"},{"issue":"7452","key":"10.1016\/j.modpat.2026.101072_bib31","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/nature12240","article-title":"Innate lymphoid cells regulate CD4+ T-cell responses to intestinal commensal bacteria","volume":"498","author":"Hepworth","year":"2013","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.modpat.2026.101072_bib32","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.cell.2015.09.033","article-title":"Comprehensive molecular portraits of invasive lobular breast cancer","volume":"163","author":"Ciriello","year":"2015","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.modpat.2026.101072_bib33","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nrc3447","article-title":"Regulatory networks defining EMT during cancer initiation and progression","volume":"13","author":"De Craene","year":"2013","journal-title":"Nat Rev Cancer"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395226001158?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395226001158?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T14:46:02Z","timestamp":1792075562000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395226001158"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":33,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S0893395226001158"],"URL":"https:\/\/doi.org\/10.1016\/j.modpat.2026.101072","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Transcriptional ILCness Score Reveals Lobular-like Biology and Clinical Behavior Beyond CDH1 Mutation Status","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.modpat.2026.101072","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 THE AUTHORS. Published by Elsevier Inc. on behalf of the United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}],"article-number":"101072"}}